GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Shenzhen Lifotronic Technology Co Ltd (SHSE:688389) » Definitions » Operating Cash Flow per Share

Shenzhen Lifotronic Technology Co (SHSE:688389) Operating Cash Flow per Share : ¥0.64 (TTM As of Mar. 2025)


View and export this data going back to 2019. Start your Free Trial

What is Shenzhen Lifotronic Technology Co Operating Cash Flow per Share?

Shenzhen Lifotronic Technology Co's operating cash flow per share for the three months ended in Mar. 2025 was ¥-0.00. Shenzhen Lifotronic Technology Co's operating cash flow per share for the trailing twelve months (TTM) ended in Mar. 2025 was ¥0.64.

During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Shenzhen Lifotronic Technology Co was -11.40% per year. During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 17.40% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 26.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for Shenzhen Lifotronic Technology Co's Operating Cash Flow per Share or its related term are showing as below:

SHSE:688389' s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: 17.4   Med: 30.3   Max: 49.7
Current: 17.4

During the past 9 years, Shenzhen Lifotronic Technology Co's highest 3-Year average Operating Cash Flow per Share Growth Rate was 49.70% per year. The lowest was 17.40% per year. And the median was 30.30% per year.

SHSE:688389's 3-Year OCF Growth Rate is ranked better than
62.36% of 696 companies
in the Medical Devices & Instruments industry
Industry Median: 8.25 vs SHSE:688389: 17.40

Shenzhen Lifotronic Technology Co Operating Cash Flow per Share Historical Data

The historical data trend for Shenzhen Lifotronic Technology Co's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shenzhen Lifotronic Technology Co Operating Cash Flow per Share Chart

Shenzhen Lifotronic Technology Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Operating Cash Flow per Share
Get a 7-Day Free Trial Premium Member Only 0.32 0.43 0.65 0.71 0.70

Shenzhen Lifotronic Technology Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Operating Cash Flow per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.06 0.14 0.21 0.29 -

Competitive Comparison of Shenzhen Lifotronic Technology Co's Operating Cash Flow per Share

For the Medical Devices subindustry, Shenzhen Lifotronic Technology Co's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shenzhen Lifotronic Technology Co's Price-to-Operating-Cash-Flow Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Shenzhen Lifotronic Technology Co's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Shenzhen Lifotronic Technology Co's Price-to-Operating-Cash-Flow falls into.


;
;

Shenzhen Lifotronic Technology Co Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

Shenzhen Lifotronic Technology Co's Operating Cash Flow per Share for the fiscal year that ended in Dec. 2024 is calculated as

Operating Cash Flow per Share (A: Dec. 2024 )=Cash Flow from Operations (A: Dec. 2024 )/Shares Outstanding (Diluted Average) (A: Dec. 2024 )
=296.471/426.409
=0.70

Shenzhen Lifotronic Technology Co's Operating Cash Flow per Share for the quarter that ended in Dec. 2024 is calculated as

Operating Cash Flow per Share (Q: Mar. 2025 )=Cash Flow from Operations (Q: Mar. 2025 )/Shares Outstanding (Diluted Average) (Q: Mar. 2025 )
=-0.903/412.959
=-0.00

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0.64

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Shenzhen Lifotronic Technology Co Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of Shenzhen Lifotronic Technology Co's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Shenzhen Lifotronic Technology Co Business Description

Traded in Other Exchanges
N/A
Address
No. 8 Qiuzhi East Road, Guanhu Street, 1st Floor, Jindi Tianyue Bay, Guancheng Community, Longhua District, Guangdong, Shenzhen, CHN, 518055
Shenzhen Lifotronic Technology Co Ltd is a China based company engaged in the development, production and sales of therapeutic and rehabilitation products, in vitro diagnostic equipment and supporting reagents.
Executives
Wang Zheng Core technical personnel
Peng Guo Qing Core technical personnel
Xiang Lei Director
Wang Hong Director
Hu Ming Long Director
Li Da Wei senior management

Shenzhen Lifotronic Technology Co Headlines

No Headlines